ADAM17 and type 2 diabetes mellitus: An increase in ADAM17-mediated shedding activity and decrease in its substrate angiotensin-converting enzyme 2 (ACE2) have been observed with the progression of type 2 diabetes mellitus (T2D) [133], suggesting the importance of this mechanism in the disease.